Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

When worlds collide: Th17 and Treg cells in cancer and autoimmunity
Hannah M. Knochelmann, Connor J. Dwyer, Stefanie R. Bailey, et al.
Cellular and Molecular Immunology (2018) Vol. 15, Iss. 5, pp. 458-469
Open Access | Times Cited: 424

Showing 1-25 of 424 citing articles:

Inflammation and tumor progression: signaling pathways and targeted intervention
Huakan Zhao, Lei Wu, Guifang Yan, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 1599
Immune-related adverse events of checkpoint inhibitors
Manuel Ramos‐Casals, Julie R. Brahmer, Margaret K. Callahan, et al.
Nature Reviews Disease Primers (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 1004
IL-6 in inflammation, autoimmunity and cancer
Toshio Hirano
International Immunology (2020) Vol. 33, Iss. 3, pp. 127-148
Open Access | Times Cited: 876
Turning cold tumors hot: from molecular mechanisms to clinical applications
Jiahui Zhang, Di Huang, Phei Er Saw, et al.
Trends in Immunology (2022) Vol. 43, Iss. 7, pp. 523-545
Closed Access | Times Cited: 312
Autoinflammatory and autoimmune conditions at the crossroad of COVID-19
Yhojan Rodríguez, Lucia Novelli, Manuel Rojas, et al.
Journal of Autoimmunity (2020) Vol. 114, pp. 102506-102506
Open Access | Times Cited: 305
Immunosuppressive cells in cancer: mechanisms and potential therapeutic targets
Yan Tie, Fan Tang, Yuquan Wei, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 294
Cytotoxic CD4+ T cells in cancer: Expanding the immune effector toolbox
David Y. Oh, Lawrence Fong
Immunity (2021) Vol. 54, Iss. 12, pp. 2701-2711
Open Access | Times Cited: 286
Moving towards personalized treatments of immune-related adverse events
Khashayar Esfahani, Arielle Elkrief, Cassandra Calabrese, et al.
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 8, pp. 504-515
Closed Access | Times Cited: 247
Immunogenic cell death induced by a new photodynamic therapy based on photosens and photodithazine
Victoria D. Turubanova, Irina V. Balalaeva, Tatiana A. Mishchenko, et al.
Journal for ImmunoTherapy of Cancer (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 227
Overcoming TGFβ-mediated immune evasion in cancer
Daniele V. F. Tauriello, Elena Sancho, Eduard Batlle
Nature reviews. Cancer (2021) Vol. 22, Iss. 1, pp. 25-44
Open Access | Times Cited: 221
Role of the NLRP3 inflammasome in autoimmune diseases
Zhe Li, Jialong Guo, Liqi Bi
Biomedicine & Pharmacotherapy (2020) Vol. 130, pp. 110542-110542
Open Access | Times Cited: 202
RNA modifications: importance in immune cell biology and related diseases
Lian Cui, Rui Ma, Jiangluyi Cai, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 194
Pas de Deux: Control of Anti-tumor Immunity by Cancer-Associated Inflammation
Shabnam Shalapour, Michael Karin
Immunity (2019) Vol. 51, Iss. 1, pp. 15-26
Open Access | Times Cited: 175
CAR T Cells in Solid Tumors: Blueprints for Building Effective Therapies
Hannah M. Knochelmann, Aubrey S. Smith, Connor J. Dwyer, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 170
IL-10 and IL-22 in Mucosal Immunity: Driving Protection and Pathology
Hua-Xing Wei, Baolong Wang, Bofeng Li
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 163
Metabolic crosstalk in the breast cancer microenvironment
Ana S. Dias, Catarina R. Almeida, Luísa A. Helguero, et al.
European Journal of Cancer (2019) Vol. 121, pp. 154-171
Closed Access | Times Cited: 162
TH17 cell heterogeneity and its role in tissue inflammation
Alexandra Schnell, Dan R. Littman, Vijay K. Kuchroo
Nature Immunology (2023) Vol. 24, Iss. 1, pp. 19-29
Open Access | Times Cited: 123
Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics
Quan Lu, Meifeng Yang, Yujie Liang, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 1825-1844
Open Access | Times Cited: 105
ALKBH5 Drives Immune Suppression Via Targeting AXIN2 to Promote Colorectal Cancer and Is a Target for Boosting Immunotherapy
Jianning Zhai, Huarong Chen, Chi Chun Wong, et al.
Gastroenterology (2023) Vol. 165, Iss. 2, pp. 445-462
Open Access | Times Cited: 59
Methylation across the central dogma in health and diseases: new therapeutic strategies
Ruochen Liu, Erhu Zhao, Huijuan Yu, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 51
Potential anti-tumor effects of regulatory T cells in the tumor microenvironment: a review
Yu Li, Cangang Zhang, Aimin Jiang, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Pulmonary toxicity of immune checkpoint immunotherapy
Mohammad I. Ghanbar, Karthik Suresh
Journal of Clinical Investigation (2024) Vol. 134, Iss. 2
Open Access | Times Cited: 21
Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
Zhuang Li, Ling Yang, Linsheng Li, et al.
MedComm (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 19
The role of transforming growth factorβin T helper 17 differentiation
Song Zhang
Immunology (2018) Vol. 155, Iss. 1, pp. 24-35
Open Access | Times Cited: 138
Polymeric nanoparticle vaccines to combat emerging and pandemic threats
David Wibowo, Sytze H.T. Jorritsma, Zennia Jean Gonzaga, et al.
Biomaterials (2020) Vol. 268, pp. 120597-120597
Open Access | Times Cited: 136
Page 1 - Next Page

Scroll to top